Therapeutic options for epithelial skin tumors: Actinic keratoses, Bowen disease, squamous cell carcinoma, and basal cell carcinoma;Therapieoptionen bei epithelialen hauttumoren: Aktinische keratosen, morbus Bowen, spinozelluläres karzinom und basalzellkarzinom

Hautarzt

Volumn 56, Issue 5, 2005, Pages 430-440

  Szeimies, R M ^a   Karrer, S ^a   Backer H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Actinic keratosis; Basal cell carcinoma; Bowen's disease; Epithelial tumors; Squamous cell carcinoma

Indexed keywords

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; EPITHELIUM TUMOR; HUMAN; ONSET AGE; REVIEW; RISK FACTOR; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ANTINEOPLASTIC AGENTS; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CRYOTHERAPY; CURETTAGE; HUMANS; KERATOSIS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS;

EID: 20144381788     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-005-0950-5     Document Type: Review

References (48)

1. Ariette JP (2003) Treatment of Bowen's disease and erythroplasia of Queyrat. Br J Dermatol 149 [Suppl 66]:43-47
2. Avril MF, Auperin A, Margulis A et al. (1997) Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study. Br J Cancer 76:100-106
3. Bell HK, Rhodes LE (1999) Bowen's disease - a retrospective review of clinical management. Clin Exp Dermatol 24:338-339
4. Bianchi L, Orlandi A, Campione E et al. (2004) Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases. Br J Dermatol 151:148-156
5. Cox NH, Eedy DJ, Morton CA (1999) Guidelines for management of Bowen's disease. Br J Dermatol 141:633-641
6. Freeman M, Vinciullo C, Francis D et al. (2003) A comparison of photodynamic therapy using topical methyl aminolevulinate (Metvix) with single cycle cryotherapy in patients with actinic keratosis: a prospective, randomized study. J Dermatolog Treat 14:99-106
7. Geisse J, Caro I, Lindholm J et al. (2004) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50:722-733
8. Giuffrida TJ, Jimenez G, Nouri K (2003) Histologic cure of basal cell carcinoma treated with cryosurgery. J Am Acad Dermatol 49:483-486
9. Hall VL, Leppard BJ, McGill J et al. (1986) Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol 37:33-34
10. Iyer S, Bowes L, Kricorian G et al. (2004) Treatment of basal cell carcinoma with the pulsed carbon dioxide laser: a retrospective analysis. Dermatol Surg 30:1214-1218
11. Iyer S, Friedli A, Bowes L et al. (2004) Full face laser resurfacing: therapy and prophylaxis for actinic keratoses and non-melanoma skin cancer. Lasers Surg Med 34:114-119
12. Karagas MR, Greenberg ER, Spencer SK et al. (1999) Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer 81:555-559
13. Kowalzick L, Rogozinski T, Wimheuer R et al. (2002) Intralesional recombinant interferon beta-1a in the treatment of basal cell carcinoma: results of an open-label multicentre study. Eur J Dermatol 12:558-561
14. Kraus S, Miller BH, Swinehart JM et al. (1998) Intratumoral chemotherapy with fluorouracil/epinephrine injectable gel: a nonsurgical treatment of cutaneous squamous cell carcinoma. J Am Acad Dermatol 38:438-442
15. Kurwa HA, Yong-Gee SA, Seed PT et al. (1999) A randomized paired comparison of photodynamic therapy and topical 5-fluorouracil in the treatment of actinic keratoses. J Am Acad Dermatol 41:414-418
16. Labandeira J, Pereiro M Jr, Valdes F, Toribio J (2004) Intermittent topical 5-fluorouracil is effective without significant irritation in the treatment of actinic keratoses but prolongs treatment duration. Dermatol Surg 30:517-520
17. Lebwohl M, Dinehart S, Whiting D et al. (2004) Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol 50:714-721
18. Loven K, Stein L, Furst K, Levy S (2002) Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis. Clin Ther 24:990-1000
19. Lubritz RR, Smolewski SA (1982) Cryosurgery cure rate of actinic keratoses. J Am Acad Dermatol 7:631-632
20. Mackenzie-Wood A, Kossard S, de Launey J et al. (2001) Imiquimod 5% cream in the treatment of Bowen,s disease. J Am Acad Dermatol 44:462-470
21. Marks R, Owens M, Walters SA (2004) Efficacy and safety of 5% imiquimod cream in treating patients with multiple superficial basal cell carcinomas. Arch Dermatol 140:1284-1285
22. Miller BH, Shavin JS, Cognetta A et al. (1997) Non-surgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. J Am Acad Dermatol 36:72-77
23. Morse LG, Kendrick C, Hooper D et al. (2003) Treatment of squamous cell carcinoma with intralesional 5-Fluorouracil. Dermatol Surg 29:1150-1153
24. Morton CA, Whitehurst C, Moseley H et al. (1996) Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease. Br J Dermatol 135:766-771
25. Nagore E, Grau C, Molinero J, Fortea JM (2003) Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 17:167-170
26. Nelson C, Rigel D, Smith S et al. (2004) Phase IV, open-label assessment of the treatment of actinic keratosis with 3.0% diclofenac sodium topical gel (Solaraze). J Drugs Dermatol 3:401-407
27. Plaza Lanza M, Ralphs I, Dawber RPR (1980) Cryosurgery for Bowen's disease of the skin. Br J Dermatol 103 [Suppl 18]:14
28. Reyman F (1979) Treatment of basal cell carcinoma of the skin with 5-Fluorouracil ointment. A 10-year follow-up study. Dermatologica 158:368-372
29. Rowe DE, Carroll RJ, Day CL Jr (1989) Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 15:424-431
30. Salim A, Leman JA, McColl JH et al. (2003) Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 148:539-543
31. Salim A, Morton CA (2000) Comparison of photodynamic therapy with topical 5-fluorouracil in Bowen's disease. Br J Dermatol 143 [Suppl 57]:114 (Abstr)
32. Seegenschmiedt MH, Oberste-Beulmann S, Lang E et al. (2001) Strahlentherapie des Basalzellkarzinoms. Lokale Kontrolle und kosmetisches Ergebnis. Strahlenther Onkol 177:240-246
33. Sheridan AT, Dawber RP (2000) Curettage, electrosurgery and skin cancer. Australas J Dermatol. 41:19-30
34. Shumack S, Gebauer K, Quirk C et al. (2004) 5% imiquimod cream for the treatment of large superficial basal cell carcinoma. Arch Dermatol 140:1286-1287
35. Silverman MK, Kopf AW, Grin CM et al. (1991) Recurrence rates of treated basal cell carcinomas. Part 2: Curettage-electrodesiccation. J Dermatol Surg Oncol 17:720-726
36. Smeets NW, Krekels GA, Ostertag JU et al. (2004) Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 364:1766-1772
37. Smeets NW, Kuijpers DI, Nelemans P et al. (2004) Mohs' micrographic surgery for treatment of basal cell carcinoma of the face - results of a retrospective study and review of the literature. Br J Dermatol 151:141-147
38. Smith KJ, Germain M, Skelton H (2001) Bowen's disease (squamous cell carcinoma in situ) in immunosuppressed patients treated with imiquimod 5% cream and a cox inhibitor, sulindac: potential applications for this combination of immunotherapy. Dermatol Surg 27:143-146
39. Stockfleth E, Meyer T, Benninghoff B et al. (2002) A randomized, double-blind, vehicle-controlled study to assess 5% imiquimod cream for the treatment of multiple actinic keratoses. Arch Dermatol 138:1498-1502
40. Szeimies RM, Gerritsen MJ, Gupta G et al. (2004) Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology. J Am Acad Dermatol 51:547-555
41. Szeimies RM, Karrer S, Radakovic-Fijan S et al. (2002) Photodynamic therapy using topical methyl 5-aminolevulinate compared with cryotherapy for actinic keratosis: a prospective, randomized study. J Am Acad Dermatol 47:258-262
42. Thai KE, Fergin P, Freeman M et al. (2004) A prospective study of the use of cryosurgery for the treatment of actinic keratoses. Int J Dermatol 43:687-692
43. Thissen MR, Nieman FH, Ideler AH et al. (2000) Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg 26:759-764
44. Turner RJ, Leonard N, Malcolm AJ et al. (2000) A retrospective study of outcome of Mohs' micrographic surgery for cutaneous squamous cell carcinoma using formalin fixed sections. Br J Dermatol 142:752-757
45. Varma S, Wilson H, Kurwa HA et al. (2001) Bowen's disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 144:567-574
46. Wang I, Bendsoe N, Klinteberg CA et al. (2001) Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 144:832-840
47. Wolf JE Jr, Taylor JR, Tschen E, Kang S (2001) Topical 3.0% diclofenac in 2.5% hyaluronan gel in the treatment of actinic keratoses. Int J Dermatol 40:709-713
48. Zeitouni NC, Shieh S, Oseroff AR (2001) Laser and photodynamic therapy in the management of cutaneous malignancies. In: Ellerin B (ed) Clinics in dermatology. Elsevier, New York, NY, pp 328-339